Evaluate the Immunogenicity of a Novel Glucagon Formulation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Locemia Solutions ULC
ClinicalTrials.gov Identifier:
NCT01959334
First received: October 5, 2013
Last updated: March 19, 2015
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)